Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | The ten leading Indian pharmaceutical companies generated over $15.5bn across FY2015GMR Data’s new pharmaceutical market report ‘The Indian Pharmaceutical Market - Leading Domestic Companies 2015’ is released today
By: GMR Data The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies; Key Drivers US Generics Market JV, Acquisitions & Mergers Patent Cliff Increased Domestic Health Spending Geographic Expansion into Semi-Regulated and Emerging Pharma Markets Economies in Drug Production/Manufacture Governmental Support Key Restraints Industry Inefficiencies Regulatory Non-Compliance Price Ceilings Intellectual Property Rights / Compulsory Licence Inadequate Health Insurance, India The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Data’s list generating over 50% of their annual revenues from the US generics market. However with access to the US market comes increased scrutiny from the US FDA; nearly all the companies in the top ten have faced warnings from the FDA; ranging from minor procedural infractions to complete manufacturing shutdown. The report contains over 130 tables & figures across 152 pages and concludes with 3 exclusive interviews with managing directors of 3 leading Indian pharmaceutical companies; · Cipla · Cadila Healthcare · IPCA Laboratories To order this report please contact Alice Morgan on TEL: +353 86 075 2687 or by emailing Alice.Morgan@ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|